Improving the clinical trial site feasibility process
The feasibility process is necessary to determine which sites have the capacity, experience and suitable patients available in order to recruit effectively. However, statistics show that less than half the sites selected deliver the numbers promised and one in ten fail to recruit a single patient. This results in costly delays to the trial completion.
Why is this area such a problem?